Sort
11,323 grants matching “glioblastoma”
ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma
$36,902Adarsha Prakash Malla · University Of Maryland Baltimore · F30 · FY2025 · CA
Neuro-Oncology Research Program
$36,890Boris Pasche · Wake Forest University Health Sciences · P30 · FY2023 · CA
Neuro-Oncology Research Program
$36,890Boris Pasche · Wake Forest University Health Sciences · P30 · FY2022 · CA
Novel Roles of LY6K in Glioblastoma Tumorigenicity
$36,744Namratha G Sastry · Northwestern University At Chicago · F31 · FY2019 · CA
Mitochondrial quality control as a selective vulnerability in cancers with chromosome 10q deletion
$36,735Jacob Michael Winter · University Of Utah · F30 · FY2021 · CA
Signaling Networks in Glioblastoma Drug Resistance
$36,724Jose Luis McFaline-Figueroa · Massachusetts Institute Of Technology · F31 · FY2013 · CA
Mechanism and Interactions of Human Pyruvate Dehydrogenase Complex with its Kinase 1.
$36,720Elena Luisa Guevara Talarico · Rutgers The State Univ Of Nj Newark · F31 · FY2015 · GM
Molecular mechanisms that regulate ADAR target recognition and RNA editing in vivo
$36,663Heather Ann Hundley · Indiana University Indianapolis · R01 · FY2022 · GM
The Function of LINC00263 in Human Glioma
$36,614David Wu · University Of California, San Francisco · F31 · FY2018 · NS
Role of GAS41 in human cancer
$36,600Xiaobing Shi · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Exploring synaptic actin-myosin dynamics with super resolution microscopy
$36,538Shayna Jordan Reed · University Of Florida · F31 · FY2025 · NS
Glycocalyx and NCOR2-Notch-Mediated Stemness in Glioblastoma Aggressiveness
$36,530Yekaterina Andreevna Miroshnikova · University Of California, San Francisco · F31 · FY2014 · CA
Therapeutic Engineered Stem Cells as a New Adjuvant Therapy for Non-Small Cell Lung Cancer Brain Metastases
$36,523Alison R. Mercer-Smith · Univ Of North Carolina Chapel Hill · F30 · FY2019 · CA
Etiology of glioma and glioblastoma
$36,506David James Cote · Harvard Medical School · F30 · FY2019 · CA
Role of Truncated GLI1 in Glioma Stem Cells
$36,416Sherona R. Sirkisoon · Wake Forest University Health Sciences · F31 · FY2018 · CA
The oncogenic functions of Neuropilin-1 in the glioblastoma tumor microenvironment
$36,401Daniel Radin · State University New York Stony Brook · F30 · FY2021 · CA
ImmunoPET Evaluation of Focused Ultrasound-mediated Delivery and Immunomodulation by anti-CD47 Immunotherapy in the Setting of Current Standard-of-Care Treatment for Glioblastoma
$36,338Adarsha Prakash Malla · University Of Maryland Baltimore · F30 · FY2024 · CA
Translational Therapeutics Research Program (TT)
$36,301David P Carbone · Ohio State University · P30 · FY2016 · CA
GABPB1L-mediated activation of the mutant TERT promoter as a therapeutic target in glioblastoma
$36,229Andrew G Mancini · University Of California, San Francisco · F99 · FY2018 · CA
NIH Administrative Supplement to Promote Diversity in Health Related Research
$36,221Carlos M Rinaldi-Ramos · University Of Florida · R01 · FY2023 · EB
Mitochondrial quality control as a selective vulnerability in cancers with chromosome 10q deletion
$36,219Jacob Michael Winter · University Of Utah · F30 · FY2020 · CA
The immunosuppressive role of glioblastoma-derived macrophage migration inhibitor factor
$36,114Tyler Joseph Alban · Cleveland Clinic Lerner Com-Cwru · F31 · FY2018 · NS
HIV NCp7 inhibitors and Multivalent Inhibition of Membrane Receptors
$36,103Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Cytokine-induced RelB phosphorylation in glioblastoma multiforme
$36,044Angela Satya Gupta · Virginia Commonwealth University · F30 · FY2018 · CA
Cytokine induced RelB/p50 complexes drive mesenchymal glioma progression
$36,044Michael Waters · Virginia Commonwealth University · F30 · FY2018 · CA